| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |